Kesatuan Eropah -
Norway -
EMA (European Medicines Agency)
sixmo
l. molteni & c. dei fratelli alitti società di esercizio s.p.a. - buprenorfin hydrochloride - opioid-relaterte lidelser - andre nervesystemet narkotika - sixmo er indikert for substitusjonsbehandling for opioidavhengighet i klinisk stabil voksne pasienter som ikke krever mer enn 8 mg/dag sublingual buprenorfin, innenfor en ramme av medisinsk, sosial og psykologisk behandling.
Kesatuan Eropah -
Norway -
EMA (European Medicines Agency)
ontilyv
bial portela & companhia s.a. - opicapone - parkinsonsykdom - anti-parkinson medisiner - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
Norway -
Norway -
Statens legemiddelverk
akynzeo 300 mg / 0.5 mg
orifarm as - netupitant / palonosetron - kapsel, hard - 300 mg / 0.5 mg
Norway -
Norway -
Statens legemiddelverk
durogesic 50 mikrog/ time
janssen-cilag as - fentanyl - depotplaster - 50 mikrog/ time
Norway -
Norway -
Statens legemiddelverk
durogesic 12 mikrog/ time
janssen-cilag as - fentanyl - depotplaster - 12 mikrog/ time
Norway -
Norway -
Statens legemiddelverk
durogesic 25 mikrog/ time
janssen-cilag as - fentanyl - depotplaster - 25 mikrog/ time
Norway -
Norway -
Statens legemiddelverk
durogesic 75 mikrog/ time
janssen-cilag as - fentanyl - depotplaster - 75 mikrog/ time
Norway -
Norway -
Statens legemiddelverk
durogesic 100 mikrog/ time
janssen-cilag as - fentanyl - depotplaster - 100 mikrog/ time
Norway -
Norway -
Statens legemiddelverk
norspan 20 mikrog/ time
mundipharma as - buprenorfin - depotplaster - 20 mikrog/ time
Norway -
Norway -
Statens legemiddelverk
norspan 5 mikrog/ time
mundipharma as - buprenorfin - depotplaster - 5 mikrog/ time